These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12048303)

  • 1. Lethal medium-vessel panarteritis mimicking deep sepsis following etanercept and minocycline therapy in a patient with severe rheumatoid arthritis.
    Berthelot JM; Glemarec J; Maugars Y; Prost A
    Rheumatology (Oxford); 2002 Jun; 41(6):703-5. PubMed ID: 12048303
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of etanercept in a patient with rheumatoid arthritis on hemodialysis.
    Sugioka Y; Inui K; Koike T
    Mod Rheumatol; 2008; 18(3):293-5. PubMed ID: 18299957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of etanercept on tenosynovitis and nodules in rheumatoid arthritis.
    Kaiser M-; Bozonnat M-; Jorgensen C; Daurès J-; Sany J
    Arthritis Rheum; 2002 Feb; 46(2):559-60. PubMed ID: 11840464
    [No Abstract]   [Full Text] [Related]  

  • 4. Etanercept tapering in rheumatoid arthritis.
    Graudal N; Jürgens G
    N Engl J Med; 2015 Jan; 372(5):489. PubMed ID: 25629752
    [No Abstract]   [Full Text] [Related]  

  • 5. Dose reduction of etanercept--can we treat more patients using a fixed budget?
    Clunie G; Voules S; Watts R
    Rheumatology (Oxford); 2003 Apr; 42(4):600-1. PubMed ID: 12649411
    [No Abstract]   [Full Text] [Related]  

  • 6. Etanercept tapering in rheumatoid arthritis.
    Emery P; Hammoudeh M; Combe B
    N Engl J Med; 2015 Jan; 372(5):489-90. PubMed ID: 25629751
    [No Abstract]   [Full Text] [Related]  

  • 7. Defining the value of structural inhibition. Is low-dose etanercept inferior to the standard dose?
    Ruderman EM
    Rheumatology (Oxford); 2012 Dec; 51(12):2118-9. PubMed ID: 23024059
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapy of rheumatoid arthritis with etanercept].
    Lamprecht P; Nitschmann S
    Internist (Berl); 2009 May; 50(5):633-4. PubMed ID: 19350212
    [No Abstract]   [Full Text] [Related]  

  • 9. Etanercept and methotrexate in rheumatoid arthritis.
    Poteliakhoff A
    Lancet; 2004 May; 363(9422):1734. PubMed ID: 15158644
    [No Abstract]   [Full Text] [Related]  

  • 10. Marked regression of pulmonary rheumatoid nodules under etanercept therapy.
    Derot G; Marini-Portugal A; Maitre B; Claudepierre P
    J Rheumatol; 2009 Feb; 36(2):437-9. PubMed ID: 19208569
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety and efficacy of etanercept beyond 10 years of therapy in North American patients with early and longstanding rheumatoid arthritis.
    Weinblatt ME; Bathon JM; Kremer JM; Fleischmann RM; Schiff MH; Martin RW; Baumgartner SW; Park GS; Mancini EL; Genovese MC
    Arthritis Care Res (Hoboken); 2011 Mar; 63(3):373-82. PubMed ID: 20957659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etanercept-associated injection-site reactions.
    Murphy FT; Enzenauer RJ; Battafarano DF; David-Bajar K
    Arch Dermatol; 2000 Apr; 136(4):556-7. PubMed ID: 10768663
    [No Abstract]   [Full Text] [Related]  

  • 13. Etanercept (Enbrel) -- an update.
    Goffe B
    Skin Therapy Lett; 2004 Dec-2005 Jan; 9(10):1-4, 9. PubMed ID: 15657632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adverse events in rheumatoid arthritis patient with etanercept therapy: the appearance of osteomalacia].
    D'Amore M; Minenna G; D'Amore S
    Recenti Prog Med; 2005 Nov; 96(11):552-5. PubMed ID: 16499162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COMET's path, and the new biologicals in rheumatoid arthritis.
    Kremer JM
    Lancet; 2008 Aug; 372(9636):347-8. PubMed ID: 18635257
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-tumor necrosis factor alpha switching in rheumatoid arthritis and juvenile chronic arthritis.
    Favalli EG; Arreghini M; Arnoldi C; Panni B; Marchesoni A; Tosi S; Pontikaki I
    Arthritis Rheum; 2004 Apr; 51(2):301-2. PubMed ID: 15077278
    [No Abstract]   [Full Text] [Related]  

  • 17. [Four-year observation of etanercept therapy for rheumatoid arthritis in a single German center].
    Schotte H; Schorat MA; Willeke P; Domschke W; Gaubitz M
    Z Rheumatol; 2005 May; 64(4):265-73. PubMed ID: 15909087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of pseudogout during etanercept treatment.
    Josefina M; Ana CJ; Ariel V; Silvio AA
    J Clin Rheumatol; 2007 Jun; 13(3):177. PubMed ID: 17551392
    [No Abstract]   [Full Text] [Related]  

  • 19. Ocular inflammatory disease in patients with RA taking etanercept: is discontinuation of etanercept necessary?
    Tiliakos AN; Tiliakos NA
    J Rheumatol; 2003 Dec; 30(12):2727. PubMed ID: 14719226
    [No Abstract]   [Full Text] [Related]  

  • 20. The economic burden of biological therapy in rheumatoid arthritis in clinical practice: cost-effectiveness analysis of sub-cutaneous anti-TNFalpha treatment in Italian patients.
    Benucci M; Li Gobbi F; Sabadini L; Saviola G; Baiardi P; Manfredi M
    Int J Immunopathol Pharmacol; 2009; 22(4):1147-52. PubMed ID: 20074482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.